Central Trust Company’s Steris STE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.8K | Sell |
329
-65
| -16% | -$15.9K | ﹤0.01% | 770 |
|
|
2025
Q4 | $99.9K | Sell |
394
-1
| -0.3% | -$251 | ﹤0.01% | 695 |
|
|
2025
Q3 | $97.7K | Sell |
395
-227
| -36% | -$54.3K | ﹤0.01% | 700 |
|
|
2025
Q2 | $149K | Sell |
622
-152
| -20% | -$35.4K | ﹤0.01% | 615 |
|
|
2025
Q1 | $175K | Sell |
774
-4
| -0.5% | -$880 | ﹤0.01% | 584 |
|
|
2024
Q4 | $160K | Sell |
778
-445
| -36% | -$97.6K | ﹤0.01% | 595 |
|
|
2024
Q3 | $297K | Sell |
1,223
-239
| -16% | -$55.9K | 0.01% | 487 |
|
|
2024
Q2 | $321K | Sell |
1,462
-173
| -11% | -$37.6K | 0.01% | 473 |
|
|
2024
Q1 | $368K | Sell |
1,635
-501
| -23% | -$113K | 0.01% | 469 |
|
|
2023
Q4 | $470K | Sell |
2,136
-332
| -13% | -$70.2K | 0.01% | 416 |
|
|
2023
Q3 | $542K | Sell |
2,468
-421
| -15% | -$95.2K | 0.02% | 393 |
|
|
2023
Q2 | $650K | Sell |
2,889
-2,861
| -50% | -$572K | 0.02% | 382 |
|
|
2023
Q1 | $1.1M | Sell |
5,750
-68
| -1% | -$13.1K | 0.03% | 294 |
|
|
2022
Q4 | $1.07M | Buy |
5,818
+1,242
| +27% | +$218K | 0.03% | 291 |
|
|
2022
Q3 | $761K | Sell |
4,576
-1,226
| -21% | -$249K | 0.03% | 316 |
|
|
2022
Q2 | $1.2M | Buy |
5,802
+5,011
| +634% | +$1.13M | 0.04% | 274 |
|
|
2022
Q1 | $191K | Buy |
791
+37
| +5% | +$8.58K | 0.01% | 579 |
|
|
2021
Q4 | $184K | Buy |
754
+26
| +4% | +$5.94K | 0.01% | 599 |
|
|
2021
Q3 | $149K | Sell |
728
-12
| -2% | -$2.57K | 0.01% | 589 |
|
|
2021
Q2 | $153K | Sell |
740
-73
| -9% | -$14.7K | 0.01% | 571 |
|
|
2021
Q1 | $155K | Sell |
813
-165
| -17% | -$30.6K | 0.01% | 540 |
|
|
2020
Q4 | $185K | Buy |
978
+5
| +0.5% | +$933 | 0.01% | 488 |
|
|
2020
Q3 | $171K | Buy |
973
+465
| +92% | +$74.3K | 0.01% | 471 |
|
|
2020
Q2 | $78K | Buy |
508
+155
| +44% | +$23.6K | ﹤0.01% | 566 |
|
|
2020
Q1 | $49K | Sell |
353
-157
| -31% | -$23.5K | ﹤0.01% | 614 |
|
|
2019
Q4 | $78K | Sell |
510
-17
| -3% | -$2.49K | ﹤0.01% | 608 |
|
|
2019
Q3 | $76K | Sell |
527
-63
| -11% | -$9.41K | ﹤0.01% | 587 |
|
|
2019
Q2 | $89K | Buy |
590
+128
| +28% | +$17.1K | 0.01% | 572 |
|
|
2019
Q1 | $59K | Sell |
462
-40
| -8% | -$4.71K | ﹤0.01% | 606 |
|
|
2018
Q4 | $54K | Sell |
502
-65
| -11% | -$7.26K | ﹤0.01% | 617 |
|
|
2018
Q3 | $65K | Buy |
567
+20
| +4% | +$2.26K | ﹤0.01% | 635 |
|
|
2018
Q2 | $57K | Buy |
+547
| New | +$55K | ﹤0.01% | 649 |
|
|
2018
Q1 | – | Sell |
-1,778
| Closed | -$156K | – | 1327 |
|
|
2017
Q4 | $156K | Sell |
1,778
-183
| -9% | -$16.3K | 0.01% | 519 |
|
|
2017
Q3 | $173K | Sell |
1,961
-92
| -4% | -$7.8K | 0.01% | 474 |
|
|
2017
Q2 | $167K | Sell |
2,053
-1,617
| -44% | -$123K | 0.01% | 476 |
|
|
2017
Q1 | $255K | Buy |
3,670
+47
| +1% | +$3.25K | 0.02% | 411 |
|
|
2016
Q4 | $244K | Buy |
3,623
+221
| +6% | +$15K | 0.02% | 412 |
|
|
2016
Q3 | $249K | Buy |
3,402
+545
| +19% | +$38.5K | 0.02% | 400 |
|
|
2016
Q2 | $196K | Buy |
2,857
+2,200
| +335% | +$154K | 0.01% | 441 |
|
|
2016
Q1 | $47K | Buy |
+657
| New | +$44.4K | ﹤0.01% | 693 |
|
Other funds holding STE
VCM
VPM
OAG
GIM
Central Trust Company's STE Position: Q1 2026 in Review
Central Trust Company reduced its Steris (STE) stake by 16% in Q1 2026, selling an estimated $15.9K and leaving 329 shares worth $72.8K. The position accounts for ﹤0.01% of the portfolio, ranked #770.
Central Trust Company first reported a position in STE in Q1 2016 and has held it in 40 quarters since. The position peaked at $1.2M in Q2 2022. 839 funds tracked by Wall St. Rank hold STE as of Q1 2026.
- Central Trust Company held 329 shares of Steris worth $72.8K as of Q1 2026.
- Central Trust Company sold 65 Steris shares in Q1 2026, an estimated $15.9K.
- Steris made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #770 holding.
- Central Trust Company first reported a position in Steris in Q1 2016 and has held it in 40 quarters since.
- Central Trust Company's Steris position peaked at $1.2M in Q2 2022.
- 839 funds tracked by Wall St. Rank held Steris as of Q1 2026.
Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.